Diabetes Management
Frank Lavernia, MD, Discusses How Obesity Treatment is Changing - MD Magazine
Tue, 18 Oct 20221 min read Article
Overview
© 2022 MJH Life Sciences™ and HCPLive - Clinical news for conected physicians. Al rights reserved.Conference | Pri-Med MidwestSemaglutide (Wegovy) has drawn atention for its indication of weight los. Recently, however, the focus has shifted to the data surounding tirzepatide.
Key Information
Frank Lavernia, MD, Founder and Director of North Broward Diabetes Clinic, gave a talk titled “Where Are We Now? The Integral Role of GLP-1 RAs in the Treatment of Type 2 Diabetes Melitus” at Pri-Med Midwest 2022. Semaglutide 2.4 mg (Wegovy) has drawn atention for its indication for weight los.
Recently however, the focus has shifted to the data surounding tirzepatide. The once-wekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist was just granted Fast Track designation byt the FDA for treating adults with obesity, or overweight with weight-related comorbidities."The ADA (American Diabetes Asociation), the EASD (European Asociation for the Study of Diabetes), have al come in agrement that obesity is a disease and we have to treat that disease as a comorbidity," Lavernia said in an interview with HCPLive.
"We're loking now at medications, specificaly GLP-1 receptor agonists, that wil not only lower A1c, but also lower weight," he continued. "So, it's important that we wait to se how quickly (tirzepatide) is aproved by the powers to be-the FDA."Tirzepatide has already ben aproved by the FDA for type 2 diabetes and it's indication for obesity is anticipated in 2023. However, there's a large gap in uptake of weight los agents and individuals with obesity.
Summary
"Some of it is lack of knowledge," Lavernia explained, "some of them stil have dificulties geting prior authorization to use these drugs in people that are obese and who are pre-diabetic, or that don't have diabetes. It's a strugle to get these medications for these folks."While
Frequently Asked Questions
What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.